Dysregulation of autism-associated synaptic proteins by psychoactive pharmaceuticals at environmental concentrations
- 1 November 2017
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 661, 143-148
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (P20GM103408)
This publication has 37 references indexed in Scilit:
- Individual and Mixture Toxicity of Pharmaceuticals Naproxen, Carbamazepine, and Sulfamethoxazole to Australian Striped Marsh Frog Tadpoles (Limnodynastes peronii)Journal of Toxicology and Environmental Health, Part A, 2014
- Drug discovery for autism spectrum disorder: challenges and opportunitiesNature Reviews Drug Discovery, 2013
- Psychoactive Pharmaceuticals Induce Fish Gene Expression Profiles Associated with Human Idiopathic AutismPLOS ONE, 2012
- The conundrums of understanding genetic risks for autism spectrum disordersNature Neuroscience, 2011
- Pharmaceuticals as Neuroendocrine Disruptors: Lessons Learned from Fish on ProzacJournal of Toxicology and Environmental Health, Part B, 2011
- The complexities of microRNA regulation: mirandering around the rulesThe International Journal of Biochemistry & Cell Biology, 2010
- Gene Regulation by Transcription Factors and MicroRNAsScience, 2008
- MicroRNAs (miRNAs) in Neurodegenerative DiseasesBrain Pathology, 2008
- Telomerase and neuronal marker status of differentiated NT2 and SK‐N‐SH human neuronal cells and primary human neuronsJournal of Neuroscience Research, 2006
- Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A.1988